Literature DB >> 978674

Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 5. Role of the asymmetric sulfonium pole in the enzymatic binding of S-adenosyl-L-methionine.

R T Borchardt, Y S Wu.   

Abstract

The configuration at the asymmetric sulfonium pole of S-adenosyl-L-methionine (SAM) necessary for optimal enzymatic binding and methyl donation has been elucidated in this study. For the transmethylations catalyzed by catechol O-methyltransferase, phenylethanolamine N-methyltransferase, histamine N-methyltransferase, and hydroxyindole O-methyltransferase, it was demonstrated that only the natural (-) enantiomer of SAM was active as a methyl donor. The corresponding (+)-SAM, which was prepared by enzymatic resolution of synthetic (+/-)-SAM, was shown to be inactive as a methyl donor in these enzymatic reactions. The (+)-SAM was found, however, to be a potent inhibitor of each of these enzyme-catalyzed transmethylations. These results suggest that the (+) enantiomer offers a nonproductive configuration for the methyl-transfer reaction itself; however, this configuration fails to hamper enzymatic binding. These results are discussed relative to the geometric requirements necessary for the methyl-transfer reaction and the requirements for enzymatic binding.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 978674     DOI: 10.1021/jm00231a004

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

2.  Binding capacities of various analogues of S-adenosyl-L-homocysteine to protein methyltransferase II from human erythrocytes.

Authors:  L Gillet; Y Looze; M Deconinck; J Léonis
Journal:  Experientia       Date:  1979-08-15

3.  Homocysteine methyltransferases Mht1 and Sam4 prevent the accumulation of age-damaged (R,S)-AdoMet in the yeast Saccharomyces cerevisiae.

Authors:  Chris R Vinci; Steven G Clarke
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

4.  Yeast, plants, worms, and flies use a methyltransferase to metabolize age-damaged (R,S)-AdoMet, but what do mammals do?

Authors:  Chris R Vinci; Steven G Clarke
Journal:  Rejuvenation Res       Date:  2010 Apr-Jun       Impact factor: 4.663

5.  Kinetic isotope effects reveal early transition state of protein lysine methyltransferase SET8.

Authors:  Joshua A Linscott; Kanishk Kapilashrami; Zhen Wang; Chamara Senevirathne; Ian R Bothwell; Gil Blum; Minkui Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-09       Impact factor: 11.205

Review 6.  AdoMet analog synthesis and utilization: current state of the art.

Authors:  Tyler D Huber; Brooke R Johnson; Jianjun Zhang; Jon S Thorson
Journal:  Curr Opin Biotechnol       Date:  2016-08-06       Impact factor: 9.740

7.  Chemoenzymatic synthesis and in situ application of S-adenosyl-L-methionine analogs.

Authors:  Marie Thomsen; Stine B Vogensen; Jens Buchardt; Michael D Burkart; Rasmus P Clausen
Journal:  Org Biomol Chem       Date:  2013-11-21       Impact factor: 3.876

8.  Preparation, Assay, and Application of Chlorinase SalL for the Chemoenzymatic Synthesis of S-Adenosyl-l-Methionine and Analogs.

Authors:  Tony D Davis; Sylvia Kunakom; Michael D Burkart; Alessandra S Eustaquio
Journal:  Methods Enzymol       Date:  2018-04-02       Impact factor: 1.600

Review 9.  SAM/SAH Analogs as Versatile Tools for SAM-Dependent Methyltransferases.

Authors:  Jing Zhang; Yujun George Zheng
Journal:  ACS Chem Biol       Date:  2015-11-16       Impact factor: 5.100

10.  An Enzyme Containing the Conserved Domain of Unknown Function DUF62 Acts as a Stereoselective (Rs ,Sc )-S-Adenosylmethionine Hydrolase.

Authors:  Taylor Kornfuehrer; Sean Romanowski; Valérie de Crécy-Lagard; Andrew D Hanson; Alessandra S Eustáquio
Journal:  Chembiochem       Date:  2020-09-16       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.